15 employees
Inflazome is a biotech company that develops orally available drugs to address inflammatory diseases by targeting inflammasomes.
2016
$46M
from 1 investors over 1 rounds
Inflazome Ltd raised $46M on November 19, 2018
Investors: Forbion